Portage Biotech Stock Analysis

Portage Stock Analysis Notes

About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of Portage Biotech was at this time reported as 4.07. The company recorded a loss per share of 68.17. Portage Biotech last dividend was issued on the 4th of June 2020. The entity had 1:20 split on the 15th of August 2024. Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. It also provides Nanolipogel co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. Portage Biotech is traded on NASDAQ Exchange in the United States. To find out more about Portage Biotech contact MD MBA at 203 221 7378 or learn more at https://www.portagebiotech.com.

Portage Biotech Investment Alerts

Portage Biotech Upcoming and Recent Events

Portage Largest EPS Surprises

View All Earnings Estimates

Portage Biotech Environmental, Social, and Governance (ESG) Scores

Portage Stock Institutional Investors

Note, although Portage Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Portage Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.66 M.

Portage Profitablity

Management Efficiency

Portage Biotech has return on total asset (ROA) of (0.1942) % which means that it has lost $0.1942 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9103) %, meaning that it created substantial loss on money invested by shareholders. Portage Biotech's management efficiency ratios could be used to measure how well Portage Biotech manages its routine affairs as well as how well it operates its assets and liabilities. The Portage Biotech's current Return On Tangible Assets is estimated to increase to -9.2. The current Return On Capital Employed is estimated to decrease to -3.91. The Portage Biotech's current Other Current Assets is estimated to increase to about 2.8 M, while Total Assets are projected to decrease to roughly 7.4 M.

Technical Drivers

As of the 11th of December 2024, Portage Biotech holds the Coefficient Of Variation of 1398.02, risk adjusted performance of 0.0612, and Semi Deviation of 6.75. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Portage Biotech, as well as the relationship between them. Please check Portage Biotech information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Portage Biotech is priced some-what accurately, providing market reflects its current price of 3.81 per share. Given that Portage Biotech has jensen alpha of 1.19, we recommend you to check out Portage Biotech's recent market performance to make sure the company can sustain itself at a future point.

Portage Biotech Price Movement Analysis

Portage Biotech Outstanding Bonds

Portage Biotech Predictive Daily Indicators

Portage Biotech Corporate Filings

Portage Biotech Forecast Models

Portage Biotech's time-series forecasting models are one of many Portage Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Portage Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Portage Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Portage shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Portage Biotech. By using and applying Portage Stock analysis, traders can create a robust methodology for identifying Portage entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Portage analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Portage analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Portage Biotech stock analysis indicators help investors evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Portage Biotech shares will generate the highest return on investment. By understating and applying Portage Biotech stock analysis, traders can identify Portage Biotech position entry and exit signals to maximize returns.

When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.